PLXS holder plans Rule 144 sale of 926 shares

A shareholder of PLXS has filed a Rule 144 notice to sell 926 shares of common stock, with an aggregate market value of $189,756.01.

Accepted by SEC EDGAR 02/02/2026 - 04:08 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder of PLXS has filed a Rule 144 notice to sell 926 shares of common stock, with an aggregate market value of $189,756.01. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 02/02/2026.

The securities were acquired as restricted stock from the issuer on 01/30/2026, and the same date is listed as the payment date. Shares outstanding for this class are reported at 26,774,415, providing context for the relative size of the proposed sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the PLXS Form 144 filing disclose?

The Form 144 for PLXS discloses a planned sale of 926 restricted common shares with an aggregate market value of $189,756.01. The filing gives notice of an intended resale of restricted securities under Rule 144 on the NASDAQ market.

How many PLXS shares are proposed to be sold under Rule 144?

The filing shows a proposed sale of 926 shares of PLXS common stock. These shares are being sold under Rule 144, which governs resales of restricted and control securities, and they are listed for execution through Morgan Stanley Smith Barney LLC on the NASDAQ exchange.

What is the aggregate market value of the PLXS shares in this Form 144?

The aggregate market value of the 926 PLXS common shares covered by this notice is $189,756.01. This figure reflects the total market value of the securities intended to be sold under Rule 144, based on the pricing used in the filing’s securities information table.

When were the PLXS shares acquired and in what form?

The PLXS shares were acquired on 01/30/2026 as restricted stock from the issuer. That same date is also listed as the payment date. Restricted stock generally cannot be freely sold immediately and must satisfy conditions, such as those in Rule 144, before resale.

When is the planned sale date for the PLXS Rule 144 shares?

The approximate sale date listed for the 926 PLXS common shares is 02/02/2026. This is the target date for executing the transaction through the designated broker on the NASDAQ, as disclosed in the securities information section of the notice.

On which exchange and through which broker will the PLXS shares be sold?

The planned sale of PLXS common stock will occur on the NASDAQ exchange. The filing names Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, as the broker handling the Rule 144 transaction for these restricted shares.

How many PLXS shares are outstanding compared to the amount being sold?

The filing reports 26,774,415 PLXS common shares outstanding, compared with 926 shares covered by this Rule 144 notice. This outstanding-share figure provides a baseline for understanding the relative scale of the proposed sale within the company’s total equity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002002072
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PLEXUS CORP.
SEC File Number	001-14423
Address of Issuer	One Plexus Way Neenah WISCONSIN 54956
Phone	(920) 969-6000
Name of Person for Whose Account the Securities are To Be Sold	MICHAEL J RUNNING
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	926	189756.01	26774415	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/30/2026	Restricted Stock	Issuer			926	01/30/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael J. Running
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)